Kapil Dhingra Insider Trading $FPRX FIVE PRIME THERAPEUTICS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Kapil Dhingra.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Kapil Dhingra. Kapil Dhingra is Director in MICROMET, INC. ($MITI) and Director in FIVE PRIME THERAPEUTICS INC ($FPRX) and Director in Black Diamond Therapeutics, Inc. ($BDTX) and Director in Replimune Group, Inc. ($REPL).
Kapil Dhingra in FIVE PRIME THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Kapil Dhingra: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 19 2021
$FPRX Market Capitalization: $1.23B
$FPRX Previous Close: $45.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Kapil Dhingra in FIVE PRIME THERAPEUTICS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BDTX, FPRX, MITI, REPL
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | D | 4.14 | 20,000 | 82,800 | 0 | |
| Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | D | 6.09 | 15,000 | 91,350 | 0 | |
| Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | D | 17.27 | 10,000 | 172,700 | 0 | |
| Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | D | 29.80 | 10,000 | 298,000 | 0 | |
| Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | D | 37.99 | 25,000 | 949,750 | 0 | |
| May 15 2020 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | A | 4.14 | 20,000 | 82,800 | 20,000 | |
| Jun 12 2019 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | A | 6.09 | 15,000 | 91,350 | 15,000 | |
| May 14 2018 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | A | 17.27 | 10,000 | 172,700 | 10,000 | |
| May 12 2017 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | A | 29.80 | 10,000 | 298,000 | 10,000 | |
| May 23 2016 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | A | 42.25 | 10,000 | 422,500 | 0 | |
| Dec 03 2015 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | A | 37.99 | 25,000 | 949,750 | 25,000 |
Page: 1